The independent source for health policy research, polling, and news.
381 - 400 of 1,685 Results
Inside the Black Equity Coalitionâs novel effort to share community health intel and scrape government data to understand â and document â the life-threatening differences between white and Black Pittsburgh.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereâs a collection of their appearances.
Experts weigh in as the federal government urges everyone to get boosted amid concerns over omicron, a new covid variant.
A Supreme Court majority appears ready to overturn nearly 50 years of abortion rights, at least judging by the latest round of oral arguments before the justices. And a new covid variant, omicron, gains attention as it spreads around the world. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Shefali Luthra of The 19th join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Blake Farmer of Nashville Public Radio about the latest KHN-NPR âBill of the Monthâ episode.
Hospitals in Montana and Idaho reported threats and harassment from public officials and family members of patients who were denied treatment with a drug not authorized to treat covid-19.
The loss of smell is a common issue for many seniors and is often overlooked. Yet it can have serious consequences.
Grieving children face grave risks to their well-being, both in the short and long term. But there is no concerted government effort to help the estimated 140,000 children who have lost a parent in the pandemic.
This new variant has set off alarm bells in the public health community, but much remains to be learned about it.
National paid sick leave provisions for covid expired, and an uncertain covid winter is around the corner. Colorado, Los Angeles and Pittsburgh are among the places trying to fill the gap, but many employees still face financial pressure to go to work while sick.
President Joe Bidenâs social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner previews next weekâs Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.
Memorial tattoos have grown more popular in recent years. Since parlors reopened after the lockdown, inkers have found that many people are eager to memorialize relatives and friends lost to covid.
The promising antiviral drugs to treat covid can halt hospitalizations and deaths, but only if theyâre given to patients within three to five days of their first symptoms, a narrow window many people wonât meet. Hereâs why.
Some business owners, wondering whether itâs too soon to ease the requirement, long for more guidance and support from the mayor.
You probably wonât be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereâs a collection of their appearances.
But state and local officials embrace the requirement because it creates a safer workplace while allowing employees to continue working.
The scientific term is âpostvention,â and it informs how to navigate the emotional challenges that follow such a tragedy.
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimerâs disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the âAn Arm and a Legâ podcast.
Health officials hope the rollout of covid shots for young children and other initiatives will boost routine vaccine rates that dropped during the pandemic and narrow socioeconomic disparities.
The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars â and cutting back services to patients â as a result.
Š 2026 KFF